Search Results - Daniel Molnar
- Showing 1 - 16 results of 16
-
1
Interkulturális szervezeti kihívások kezelése by Dániel Molnár
Published in Humán Innovációs Szemle (2024-06-01)Get full text
Article -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Cost-effectiveness analysis of respiratory syncytial virus vaccination with the adjuvanted prefusion F protein vaccine (RSVPreF3 OA) for adults ≥60 years old in Japan by Akiko Mizukami, Victor Preckler, Frederik Verelst, Taizo Matsuki, Yufan Ho, Daisuke Kurai, Daniel Molnar
Published in Expert Review of Vaccines (2024-12-01)Get full text
Article -
10
The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis by Daisuke Kurai, Akiko Mizukami, Victor Preckler, Frederik Verelst, Daniel Molnar, Taizo Matsuki, Yufan Ho, Ataru Igarashi
Published in Expert Review of Vaccines (2024-12-01)Get full text
Article -
11
Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United States by Elizabeth M. La, Jonathan Graham, David Singer, Daniel Molnar, Sara Poston, Desmond Curran, Jessica Pickett, Frederik Verelst
Published in Human Vaccines & Immunotherapeutics (2024-12-01)Get full text
Article -
12
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States by Daniel Molnar, Elizabeth M. La, Frederik Verelst, Sara Poston, Jonathan Graham, Laure-Anne Van Bellinghen, Desmond Curran
Published in Infectious Diseases and Therapy (2024-03-01)Get full text
Article -
13
Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting by Markus Ries, Brice Moulari, Maryam A. Shetab Boushehri, Mohamed Ehab Ali, Daniel Molnar, Arnaud Béduneau, Yann Pellequer, Alf Lamprecht
Published in Pharmaceutics (2022-02-01)Get full text
Article -
14
Rule of Prevention: a potential framework to evaluate preventive interventions for rare diseases by Eddie Gibson, Daniel A. Ollendorf, Steven Simoens, David E Bloom, Federico Martinón-Torres, David Salisbury, Johan Louis Severens, Mondher Toumi, Daniel Molnar, Kinga Meszaros, Woo-Yun Sohn, Najida Begum
Published in Journal of Market Access & Health Policy (2023-12-01)Get full text
Article -
15
Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany by Daniel Molnar, Anastassia Anastassopoulou, Barbara Poulsen Nautrup, Ruprecht Schmidt-Ott, Martin Eichner, Markus Schwehm, Gael Dos Santos, Bernhard Ultsch, Rafik Bekkat-Berkani, Alfred von Krempelhuber, Ilse Van Vlaenderen, Laure-Anne Van Bellinghen
Published in Human Vaccines & Immunotherapeutics (2022-11-01)Get full text
Article -
16
In situ captured antibacterial action of membrane-incising peptide lamellae by Kamal el Battioui, Sohini Chakraborty, András Wacha, Dániel Molnár, Mayra Quemé-Peña, Imola Cs. Szigyártó, Csenge Lilla Szabó, Andrea Bodor, Kata Horváti, Gergő Gyulai, Szilvia Bősze, Judith Mihály, Bálint Jezsó, Loránd Románszki, Judit Tóth, Zoltán Varga, István Mándity, Tünde Juhász, Tamás Beke-Somfai
Published in Nature Communications (2024-04-01)Get full text
Article
